- Home
- DDL vs BNTC Comparison
DDL vs BNTC Comparison
Compare DDL & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDL
- BNTC
- Stock Information
- Founded
- DDL 2014
- BNTC 1995
- Country
- DDL China
- BNTC United States
- Employees
- DDL N/A
- BNTC N/A
- Industry
- DDL Catalog/Specialty Distribution
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- DDL Consumer Discretionary
- BNTC Health Care
- Exchange
- DDL Nasdaq
- BNTC Nasdaq
- Market Cap
- DDL 457.4M
- BNTC 366.6M
- IPO Year
- DDL 2021
- BNTC N/A
- Fundamental
- Price
- DDL $2.03
- BNTC $11.47
- Analyst Decision
- DDL
- BNTC Strong Buy
- Analyst Count
- DDL 0
- BNTC 6
- Target Price
- DDL N/A
- BNTC $23.83
- AVG Volume (30 Days)
- DDL 449.5K
- BNTC 208.6K
- Earning Date
- DDL 08-06-2025
- BNTC 05-14-2025
- Dividend Yield
- DDL N/A
- BNTC N/A
- EPS Growth
- DDL N/A
- BNTC N/A
- EPS
- DDL 0.18
- BNTC N/A
- Revenue
- DDL $3,241,404,122.00
- BNTC N/A
- Revenue This Year
- DDL $8.80
- BNTC N/A
- Revenue Next Year
- DDL $11.75
- BNTC N/A
- P/E Ratio
- DDL $11.46
- BNTC N/A
- Revenue Growth
- DDL 17.62
- BNTC N/A
- 52 Week Low
- DDL $1.62
- BNTC $6.91
- 52 Week High
- DDL $4.79
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- DDL 44.45
- BNTC 32.18
- Support Level
- DDL $1.99
- BNTC $13.60
- Resistance Level
- DDL $2.29
- BNTC $15.62
- Average True Range (ATR)
- DDL 0.09
- BNTC 1.30
- MACD
- DDL 0.02
- BNTC -0.41
- Stochastic Oscillator
- DDL 21.33
- BNTC 0.52
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.